SCHEMBL18137965

SCHEMBL18137965

CCCN(C)Cc1cccc2ccncc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HTR1D P28221 1/20 0.40
▸ HTR1B P28222 1/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ RAD52 P43351 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TNF P01375 1/20 0.40
▸ HTR2A P28223 4/20 0.39
▸ NR1I2 O75469 2/20 0.39
▸ SLC6A2 P23975 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14542581 0.81 CYP2D6 (0.76) CYP2D6CYP1A2CYP2C19L3MBTL1ALDH1A1
SCHEMBL18137970 0.80 ALDH1A1 (0.50) CYP2D6CYP1A2CYP2C19KDM4EL3MBTL1
SCHEMBL6114956 0.78 TNF (0.46) CYP2D6CYP1A2CYP2C19KDM4EALDH1A1
SCHEMBL6115125 0.77 TNF (0.49) CYP2D6CYP1A2CYP2C19KDM4EL3MBTL1
SCHEMBL21674319 0.77 KDM4E (0.55) CYP2D6CYP1A2CYP2C19KDM4EL3MBTL1
SCHEMBL6114803 0.75 TNF (0.44) KDM4EL3MBTL1ALDH1A1LMNATNF
SCHEMBL6115311 0.74 TDP1 (0.47) L3MBTL1TNFKCNH2CNR1
SCHEMBL18714766 0.73 CYP2D6 (0.73) CYP2D6CYP1A2CYP2C19KDM4EL3MBTL1
SCHEMBL6114990 0.73 TDP1 (0.46) L3MBTL1TNFKCNH2CNR1
SCHEMBL6115127 0.73 TDP1 (0.46) L3MBTL1TNFKCNH2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME CMA1, CHIA, AADAC CYP2D6 494/4885CYP1A2 569/4885CYP2C19 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback